Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, May 19, 2021
[ Wed, May 19th 2021
] - WOPRAI
[ Wed, May 19th 2021
] - WOPRAI
[ Wed, May 19th 2021
] - WOPRAI
[ Wed, May 19th 2021
] - WOPRAI
[ Wed, May 19th 2021
] - WOPRAI
[ Wed, May 19th 2021
] - WOPRAI
[ Wed, May 19th 2021
] - WOPRAI
[ Wed, May 19th 2021
] - WOPRAI
[ Wed, May 19th 2021
] - WOPRAI
[ Wed, May 19th 2021
] - WOPRAI
[ Wed, May 19th 2021
] - WOPRAI
[ Wed, May 19th 2021
] - WOPRAI
[ Wed, May 19th 2021
] - WOPRAI
[ Wed, May 19th 2021
] - WOPRAI
[ Wed, May 19th 2021
] - WOPRAI
[ Wed, May 19th 2021
] - WOPRAI
[ Wed, May 19th 2021
] - WOPRAI
[ Wed, May 19th 2021
] - WOPRAI
[ Wed, May 19th 2021
] - WOPRAI
[ Wed, May 19th 2021
] - WOPRAI
[ Wed, May 19th 2021
] - WOPRAI
[ Wed, May 19th 2021
] - WOPRAI
[ Wed, May 19th 2021
] - WOPRAI
[ Wed, May 19th 2021
] - WOPRAI
[ Wed, May 19th 2021
] - WOPRAI
[ Wed, May 19th 2021
] - WOPRAI
[ Wed, May 19th 2021
] - WOPRAI
[ Wed, May 19th 2021
] - WOPRAI
[ Wed, May 19th 2021
] - WOPRAI
Tue, May 18, 2021
[ Tue, May 18th 2021
] - WOPRAI
Justin Zelin Initiated (CASI) at Strong Buy and Held Target at $40 on, May 18th, 2021
Justin Zelin of BTIG, Initiated "CASI Pharmaceuticals, Inc." (CASI) at Strong Buy and Held Target at $40 on, May 18th, 2021.
Justin has made no other calls on CASI in the last 4 months.
There are 2 other peers that have a rating on CASI. Out of the 2 peers that are also analyzing CASI, 0 agree with Justin's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Justin
- Sean Lee of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $40 on, Friday, May 14th, 2021
- Difei Yang of "Mizuho" Initiated at Strong Buy and Held Target at $38 on, Monday, April 26th, 2021
